Skip to content
New: 30 more Indian companies explained, from Ather and Pine Labs to IDBI Bank

Fast Moving Consumer Goods · NSE: DABUR · BSE: 500096

Dabur: how the business works

Dabur sells Ayurveda-based health products, hair oils, toothpaste, juices and spices to households in India and abroad, earning ₹13,193 crore of revenue in FY26.

Follow Dabur

Email me when Dabur's page is updated after results.

We store your email address with Kit, our email provider, which also records when you sign up and whether you open or click our emails. We send a confirmation email first. See our privacy policy.

Dabur India Limited · New Delhi, Delhi · Founded 1884

Updated for Q2 FY27 · checked

Revenue, FY26
₹13,193 cr
Net profit, FY26
₹1,895 cr
Shops it supplies directly, FY26
1.52 million
Founded
1884
Promoter holding, Sep 2026
66.25%

For learning only. Cityfort is not a SEBI-registered adviser and does not recommend buying or selling any security. Prices shown are dated and may be out of date.

The short version

Dabur in 5 points

  1. 1 · What it sells

    Dabur sells Ayurveda-based health products such as Dabur Chyawanprash and Hajmola, hair oils, toothpaste, Real juices and Badshah spices, and its FY26 revenue was ₹13,193 crore.

    More: what it sells

  2. 2 · Who pays it

    Households pay through shops and online stores; the company says 27% of FY26 revenue came from outside India, which leaves 73% from India.

    More: who pays it

  3. 3 · What it keeps from ₹100

    Of every ₹100 that came in during FY26, Dabur kept ₹13.7 as net profit, and ₹4.3 of that ₹100 was other income; its EBITDA margin on sales was 18.5%.

    More: what it keeps from ₹100

  4. 4 · Where the operating profit comes from

    Consumer care (health, hair, oral, skin and home care) earned ₹2,476 crore, or 90.6%, of Dabur's ₹2,731 crore FY26 segment result, on 82.3% of revenue.

    More: where the operating profit comes from

  5. 5 · The one thing to watch

    Dabur's Q2 FY27 revenue rose 11.6%, but its EBITDA margin was 17.7% against 18.4% a year earlier, and its Global CEO resigned with effect from 13 Nov 2026.

    More: the one thing to watch

Sources: From Dabur's FY26 annual report, its Q2 FY27 results and its NSE filings · checked

01Where the money goes · FY26

Where does ₹100 of Dabur's money go?

Of every ₹100 that came in (revenue plus other income), this is where it went.

Dabur · FY26

Receipt for every ₹100

Where ₹100 of Dabur's money went in FY26
Materials and goods bought₹49.5
Employee costs₹10.0
Advertising and publicity₹6.4
Other running costs₹12.0
Depreciation and interest₹4.5
Income tax₹4.0
Kept as profit₹13.7
Total₹100

Each line = amount ÷ total money in × 100. Lines may not add to exactly ₹100 because of rounding.

How this is worked out

Cityfort calculation from the FY26 annual report: each line ÷ total money in (revenue ₹13,193 crore + other income ₹600 crore = ₹13,792 crore). Other income was ₹4.3 of every ₹100. Lines add to ₹100.1: minority partners' ₹26 crore share of subsidiary losses is more than a ₹15 crore one-off labour-code charge and a ₹2 crore joint-venture loss.

Save this receipt as an image

Embed this receipt or the key numbers

Paste this code into a blog or website to show the card you choose, with a link back to this page.

Each week: the next company due to report results, explained in 5 points.

We'll email you once a week with what changed on Cityfort. Facts only, no tips. Unsubscribe any time.

We store your email address with Kit, our email provider, which also records when you sign up and whether you open or click our emails. We send a confirmation email first. See our privacy policy.

02The business in one line

What does Dabur do?

Households pay Dabur for Chyawanprash, Hajmola, hair oils, toothpaste and Real juices; about half of the money goes on materials, and ₹13.7 of every ₹100 that came in during FY26 was left as profit.

  • Shoppers buy through distributors, small shops, supermarkets and online stores. Dabur supplied 1.52 million shops directly in FY26.
  • Dabur says 27% of FY26 revenue came from outside India, from brands such as Hobi in Turkey and Namaste in the US.

03Who pays it

Who pays Dabur?

  • Households in India

    73%

    of revenue

    They buy through distributors, small shops, supermarkets and online stores; Dabur supplied 1.52 million shops directly and reached 8.5 million in all in FY26. Their 73% share is 100% minus the international share (Cityfort calculation).

  • Households abroad

    27%

    of revenue

    Middle East 27% of the international business, Africa 23%, Asia 19%, Europe 16% and the Americas 15%, the company says.

  • Households in India73%
  • Households abroad27%

How spread out the customers are

Dabur does not disclose revenue by customer; its FY26 accounts say no single customer gave 10% or more of revenue.

04How it makes money

How does Dabur make money?

Dabur earns most of its profit from low-priced health and personal care products that households buy again and again; consumer care gave 90.6% of its FY26 segment result.

Consumer care earned ₹22.8 of segment result (profit before interest, tax and shared costs) per ₹100 of its revenue in FY26, against ₹11.9 in the food business (Cityfort calculation). Its small packs reach 8.5 million shops. Material prices and advertising move the margin.

Consumer care segment result per ₹100 of its revenue (Cityfort calculation)

₹24.1₹22.8

FY22 to FY26

  1. Households buy small packs of Chyawanprash, hair oil and toothpaste again and again.
  2. Dabur supplies 1.52 million shops directly and reaches 8.5 million through distributors.
  3. Materials take ₹49.5 of every ₹100 that comes in, so herb, oil and packaging prices matter.
  4. Advertising takes ₹6.4 more, to keep brands such as Hajmola and Dabur Amla known.
  5. Consumer care earns ₹22.8 per ₹100 of its revenue; food earns ₹11.9.
  6. Profit pays dividends (₹1,419 crore in FY26) and buys brands such as Badshah and Sesa Care.

↺ Step 6 feeds back into step 1.

05Business segments · FY26

Which businesses make up Dabur?

  • Consumer care

    82.3%

    Health care, hair, oral, skin and home care in India and abroad: 82.3% of FY26 revenue. It earned ₹2,476 crore, 90.6% of the ₹2,731 crore FY26 segment result.

    Revenue ₹10,864 cr · Operating profit ₹2,476 cr

  • Food

    15.3%

    Real juices, other drinks, cooking pastes and Badshah spices. Revenue was ₹2,179 crore in FY24.

    Revenue ₹2,016 cr · Operating profit ₹240 cr

  • Retail

    0.8%

    NewU beauty stores; a ₹6 crore loss in FY26.

    Revenue ₹107 cr · Operating profit −₹6 cr

  • Other

    1.3%

    Guar gum, pharmaceuticals and other small lines.

    Revenue ₹167 cr · Operating profit ₹22 cr

  • Unallocated

    0.3%

    Other operating revenue not assigned to a segment.

    Revenue ₹39 cr

How the mix changed

  • Consumer care
  • Food
  • Retail
  • Other
  • Unallocated

Revenue by segment, FY22 to FY26.

₹ crore

See the numbers
How the mix changed (₹ crore)
YearConsumer careFoodRetailOtherUnallocated
FY22₹9,194₹1,461₹77₹123₹33
FY23₹9,262₹1,982₹111₹138₹38
FY24₹9,942₹2,179₹123₹123₹37
FY25₹10,160₹2,101₹115₹150₹37
FY26₹10,864₹2,016₹107₹167₹39

06The numbers · Consolidated · ₹ crore

How has Dabur done?

Revenue

₹13,193 crFY26

Revenue rose every year from ₹10,889 crore in FY22 to ₹13,193 crore in FY26, though growth slowed to 1.3% in FY25 and 5.0% in FY26; Q2 FY27 revenue was up 11.6% on Q2 FY26.

₹ crore

See the numbers
Revenue (₹ crore)
PeriodRevenue (₹ cr)
FY22₹10,889
FY23₹11,530
FY24₹12,404
FY25₹12,563
FY26₹13,193
Q4 FY24₹2,815
Q1 FY25₹3,349
Q2 FY25₹3,029
Q3 FY25₹3,355
Q4 FY25₹2,830
Q1 FY26₹3,405
Q2 FY26₹3,191
Q3 FY26₹3,559
Q4 FY26₹3,038
Q1 FY27₹3,764
Q2 FY27₹3,563

Net profit

₹1,895 crFY26

Net profit was ₹1,739 crore in FY22 and ₹1,895 crore in FY26, with dips in FY23 (₹1,707 crore) and FY25 (₹1,768 crore); the January–March quarter earned the least in FY25 and FY26.

₹ crore

See the numbers
Net profit (₹ crore)
PeriodNet profit (₹ cr)EPS (₹)
FY22₹1,739₹9.84
FY23₹1,707₹9.64
FY24₹1,843₹10.40
FY25₹1,768₹9.97
FY26₹1,895₹10.69
Q4 FY24₹350₹1.97
Q1 FY25₹500₹2.82
Q2 FY25₹425₹2.40
Q3 FY25₹522₹2.95
Q4 FY25₹320₹1.81
Q1 FY26₹514₹2.90
Q2 FY26₹453₹2.55
Q3 FY26₹560₹3.16
Q4 FY26₹369₹2.08
Q1 FY27₹591₹3.33
Q2 FY27₹506₹2.85

Net profit for every ₹100 of revenue

₹14.4FY26

The EBITDA margin (profit before interest, tax and wear-and-tear, per ₹100 of sales; Cityfort calculation, after one-off items) was 19.9% in FY22 and 18.5% in FY26; in Q2 FY27 it was 17.7%, against 18.4% in Q2 FY26, which the company put down to inflation.

Net margin: ₹ of net profit per ₹100 of revenue

See the numbers
Net profit for every ₹100 of revenue (Net margin: ₹ of net profit per ₹100 of revenue)
YearNet marginEBITDA margin
FY2216.0%19.9%
FY2314.8%18.8%
FY2414.9%19.3%
FY2514.1%18.4%
FY2614.4%18.5%

Free cash flow

₹2,158 crFY26

Free cash flow (cash left after running and investing in the business) was positive every year from FY22 to FY26 and reached ₹2,158 crore in FY26, when Dabur paid ₹1,419 crore of dividends.

₹ crore · cash from operations minus spending on plants and equipment

See the numbers
Free cash flow (₹ crore · cash from operations minus spending on plants and equipment)
YearCash from operationsCapital spendingFree cash flow
FY22₹1,802₹374₹1,428
FY23₹1,488₹509₹979
FY24₹2,013₹564₹1,450
FY25₹1,987₹570₹1,417
FY26₹2,579₹420₹2,158
See all yearly numbers
Dabur annual financials, FY22–FY26, ₹ crore
YearRevenueEBITDANet profitEPS (₹)Operating cashCapexFree cash
FY22₹10,889₹2,167₹1,739₹9.84₹1,802₹374₹1,428
FY23₹11,530₹2,162₹1,707₹9.64₹1,488₹509₹979
FY24₹12,404₹2,400₹1,843₹10.40₹2,013₹564₹1,450
FY25₹12,563₹2,317₹1,768₹9.97₹1,987₹570₹1,417
FY26₹13,193₹2,435₹1,895₹10.69₹2,579₹420₹2,158

EBITDA = profit before interest, tax and wear-and-tear of assets. Financial year runs April to March (March year end). Net profit is the share belonging to the company's owners.

07Who runs it

Who runs Dabur, and did they deliver?

  • Mohit Burman

    Chairman (non-executive, promoter family)

    One of four non-executive promoter directors on the 12-member board.

  • Herjit Singh Bhalla

    CEO, India business; whole-time director · since 2026

    Joined the board on 14 Nov 2026 for five years, subject to regulatory approvals. The company said there will be no new global CEO.

  • P. D. Narang

    Whole-time director

    With Dabur since 1983; oversees the international business from Nov 2026.

  • Ankush Jain

    Chief Financial Officer

    Also compliance officer from 1 Dec 2026.

  • Mohit Malhotra

    Global CEO (until 13 Nov 2026)

    Resigned with effect from 13 Nov 2026. The board filing cites personal interests; his letter says he accepted a leadership role overseas.

What they said, and what happened

2 delivered · 3 too early to tell

  1. Said on 30 Oct 2025

    Then Global CEO Mohit Malhotra said revenue growth for the second half of FY26 would be "mid to high single digit".

    What happened

    H2 FY26 revenue was ₹6,597 crore, 6.6% above H2 FY25 (Cityfort calculation from the quarterly results).

    Delivered
  2. Said on 29 Jan 2026

    Malhotra said Q4 FY26 revenue growth should be in "high single digits", with a higher EBITDA margin than a year earlier.

    What happened

    Q4 FY26 revenue rose 7.3%, and the EBITDA margin (Cityfort calculation) was 15.2%, against 15.1% in Q4 FY25.

    Delivered
  3. Said on 7 May 2026

    Malhotra raised FY27 revenue guidance from high single digit to "high single to a low double-digit growth".

    What happened

    H1 FY27 revenue was up 11.1%; the full year ends 31 Mar 2027.

    Too early to tell
  4. Said on 5 Nov 2026

    Bhalla said the company aims to take premium brands to 23% of the India business "over the next 18 months".

    What happened

    Premium brands were 20% of the India business in Q2 FY27, the company said.

    Too early to tell
  5. Said on 5 Nov 2026

    Bhalla said cost savings of ₹115 crore must be raised 1.5 times, which he put at ₹170–200 crore.

    What happened

    No period was given for the target.

    Too early to tell

08What could go wrong

What could go wrong for Dabur?

  • Raw-material prices

    Rising material costs

    Materials took ₹49.5 of every ₹100 that came in during FY26. In May 2026 Malhotra put input inflation at about 10%, and the EBITDA margin fell to 17.7% in Q2 FY27 from 18.4% a year earlier.

    Watch The EBITDA margin each quarter and price increases the company announces.

  • Currency

    Middle East and currency swings abroad

    The international business was 27% of FY26 revenue, and the Middle East was its largest region at 27%. The company described "severe headwinds in the Middle East" in Q2 FY27.

    Watch International growth in rupees and in constant currency each quarter.

  • Regulation

    Regulators in India and the US

    In 2026 the US FDA put drugs from the Silvassa plant on an import alert. India's food regulator FSSAI barred "100%" claims on some food products (stayed by the Delhi High Court), and SEBI sent a warning letter alleging a late disclosure.

    Watch The Delhi High Court hearing on 16 Dec 2026 and any US FDA update on Silvassa.

  • Execution

    New leadership and strategy

    The Global CEO resigned with effect from 13 Nov 2026, and the company said there will be no new global CEO. Bhalla said a full strategy review will come back "in the next 6 to 8 months".

    Watch The revised strategy and whether FY27 revenue growth stays in double digits.

  • Execution

    Food business margins

    Food earned ₹11.9 per ₹100 of revenue in FY26, down from ₹12.7 in FY25, and its revenue fell 4.0% in FY26 (Cityfort calculation).

    Watch Food segment revenue and result in the quarterly filings.

  • Legal

    Tax claims

    Claims not provided for in the accounts were ₹820 crore on 31 Mar 2026, including ₹684 crore of sales tax claims, up from ₹62 crore a year earlier.

    Watch Contingent liabilities in the FY27 annual report.

09Supporters and critics

What do supporters and critics point to?

Facts each side points to. We don't say which side is right.

What supporters point to

  • Cash and investments exceeded borrowings by ₹8,426 crore on 31 Mar 2026, and CRISIL reaffirmed its AAA rating on 17 Nov 2026.
  • Free cash flow was ₹2,158 crore in FY26, up from ₹1,417 crore in FY25.
  • H1 FY27 revenue rose 11.1% and profit after tax 13.4%, the company reported.
  • Dabur supplied 1.52 million shops directly in FY26, and no promoter shares were pledged in any of the 12 quarters to Sep 2026.

What critics point to

  • Revenue grew 1.3% in FY25 and 5.0% in FY26, and net profit was ₹1,895 crore in FY26 against ₹1,739 crore in FY22.
  • The Q2 FY27 EBITDA margin was 17.7%, down from 18.4% a year earlier.
  • The Global CEO resigned with effect from 13 Nov 2026. In 2026 Dabur also received a US FDA import alert (Jun), an FSSAI order (Aug, stayed by the Delhi High Court) and a SEBI administrative warning letter (Nov).
  • Foreign investors' holding fell from 16.49% in Dec 2023 to 9.61% in Sep 2026.

10What to watch next

What should you watch next at Dabur?

Next event

Q3 FY27 results (date not announced; Q3 FY26 results came on 29 Jan 2026)

Date not announced yet.

  • FY27 revenue guidance

    Bhalla repeated the double-digit revenue growth guidance for FY27 on 5 Nov 2026. H1 FY27 revenue was up 11.1%.

  • Delhi High Court, 16 Dec 2026

    The court's stay on FSSAI's order about "100%" claims on some food products continues until the next hearing on 16 Dec 2026.

  • The new strategy

    Bhalla said on 5 Nov 2026 the company will return with a revised strategy "in the next 6 to 8 months", and plans 150–200 basis points (1.5–2 percentage points) more advertising spend.

11Key facts

Key facts about Dabur

What does Dabur India do?
Dabur India sells Ayurveda-based health products such as Dabur Chyawanprash and Hajmola, hair oils, toothpaste, Real juices, Badshah spices and home care products. Its FY26 consolidated revenue was ₹13,193 crore.
How does Dabur India make money?
Dabur India earns most of its profit from its consumer care business (health, hair, oral, skin and home care), which gave ₹2,476 crore, or 90.6%, of its ₹2,731 crore FY26 segment result.
Who are Dabur India's customers?
Dabur India sells to households through distributors, shops, supermarkets and online stores. No single customer gave 10% or more of its FY26 revenue, and it supplied 1.52 million shops directly that year.
How big is Dabur India?
Dabur India's FY26 consolidated revenue was ₹13,193 crore and its net profit ₹1,895 crore. It had 7,745 employees worldwide, 4,768 of them in India.
Who owns Dabur India?
Dabur India's promoter group held 66.25% of the shares on 30 Sep 2026, with none pledged. Domestic institutions held 18.35% and foreign investors 9.61%.
How much of Dabur India's revenue comes from outside India?
Dabur India says its international business was 27% of FY26 consolidated revenue. It sells in more than 120 countries and has 8 manufacturing locations outside India.
How much dividend did Dabur India pay for FY26?
Dabur India's dividend for FY26 was ₹8.25 per share: ₹2.75 interim plus a ₹5.50 final dividend recommended by the board. It paid ₹1,419 crore of dividends in cash during FY26.
Does Dabur India have much debt?
On 31 Mar 2026 Dabur India had ₹1,063 crore of borrowings and ₹9,489 crore of cash and investments, so its cash and investments exceeded its borrowings by ₹8,426 crore.

Terms on this page

Each explains the term in plain English, with the same number from other companies on Cityfort.

Go deeper

More detail from the same filings. Open any section.

12What it sells

12What it sells

What does Dabur sell?

Dabur makes everyday products based on Ayurveda, India's traditional system of herbal medicine. Most are low-priced items bought again and again: a jar of Chyawanprash, a bottle of hair oil, a tube of toothpaste. Shares below are of FY26 India FMCG sales, as the annual report gives them.
  • Hair care (20% of India FMCG sales)

    Dabur Amla and Vatika hair oils and shampoos.

  • Oral care (19%)

    Dabur Red toothpaste, Meswak and Lal Dant Manjan tooth powder.

  • Health supplements (14%)

    Dabur Chyawanprash, a herbal jam eaten for immunity, and Dabur Honey.

  • Digestives and medicines (6% and 8%)

    Hajmola and Pudin Hara for digestion, Sat Isabgol, and Honitus cough remedies sold over the counter.

  • Juices, foods and spices (15% and 6%)

    Real fruit juices, Hommade cooking pastes and Badshah spice blends.

  • Home and skin care (8% and 4%)

    Odonil air fresheners, Sanifresh toilet cleaner, Gulabari rose water and OxyLife skin care.

What it does

  • Does: Sells in more than 120 countries; the international business was 27% of FY26 revenue, the company says.
  • Does: Makes its products in 12 factories in India and at 8 locations abroad.
  • Does: Runs a small chain of NewU beauty stores (₹107 crore of revenue in FY26).

What it does not do

  • Does not: It is not only an Ayurveda medicine maker: juices, foods and spices were 15.3% of FY26 revenue.
  • Does not: It does not depend on one big buyer: no customer gave 10% or more of FY26 revenue.
13How the money flows

13How the money flows · FY26

How does money flow through Dabur?

Money in

  • Revenue from operations₹13,193 cr
  • Other income₹600 cr

The company

Dabur

₹13,793 cr came in

Money out

  • Materials and goods bought₹6,824 cr
  • Employee costs₹1,376 cr
  • Advertising and publicity₹888 cr
  • Other running costs₹1,653 cr
  • Depreciation and interest₹614 cr
  • Income tax₹552 cr
  • Net profit₹1,895 cr
  1. In FY26 Dabur's products brought in ₹13,193 crore of revenue, plus ₹600 crore of other income.
  2. Herbs, oils, packaging and goods bought for resale took ₹6,824 crore. Employees took ₹1,376 crore.
  3. Advertising took ₹888 crore, and other running costs such as freight and selling took ₹1,653 crore.
  4. Depreciation (₹469 crore) and interest (₹145 crore) took ₹614 crore. Income tax took ₹552 crore.
  5. ₹1,895 crore was left as net profit for Dabur's shareholders.
14What it needs to run

14What it needs to run

What does Dabur need to run?

  • Factories

    12 manufacturing units in India and 8 abroad; a new plant at Tindivanam, Tamil Nadu, was under construction in FY26.

  • Warehouses and agents

    3 mother warehouses and 26 carrying-and-forwarding agents move stock to distributors.

  • Herbs and materials

    Materials and goods bought took ₹49.5 of every ₹100 that came in during FY26; Dabur also runs 8 Bio Research Division (BRD) farms.

  • People

    7,745 employees worldwide in FY26, 4,768 of them in India.

  • Product development

    ₹44.24 crore spent on research and development in FY26, with 15+ new products launched.

15Where it sells

15Where it sells · FY26

Where does Dabur sell?

  • India73%
  • Outside India27%
16Where growth could come from

16Where growth could come from

Where could Dabur's growth come from?

Herjit Singh Bhalla, CEO of the India business, said at the 5 Nov 2026 investor meet that the company is "reiterating our guidance for the full year to remain at double-digit" revenue growth for FY27. H1 FY27 revenue was up 11.1%.
Management statement, 5 Nov 2026. Reported as a statement, not our forecast.
  • Premium brands

    Working

    20% of the India business in Q2 FY27

    The company said premium brands grew 4 times as fast as regular ones in Q2 FY27. Bhalla said on 5 Nov 2026 the aim is 23% "over the next 18 months".

    Status: Working, on track against what the company said.

  • International business

    Working

    Revenue up 20.0% in rupees in Q2 FY27

    Egypt, Turkey, Bangladesh and Sub-Saharan Africa led, the company said, despite disruption in the Middle East, its largest overseas region.

    Status: Working, on track against what the company said.

  • Food and beverages

    Mixed

    Up 17.4% in Q2 FY27, after a fall in FY26

    Food segment revenue fell to ₹2,016 crore in FY26 from ₹2,101 crore in FY25, then grew in Q1 and Q2 FY27.

    Status: Mixed, partly on track.

  • Health care

    Mixed

    Up 6.9% in Q2 FY27

    Digestives grew, but the company said health supplements were held back by a change to new packs and labels.

    Status: Mixed, partly on track.

  • Sesa Care hair care merger

    New

    Sanctioned by the NCLT on 24 Sep 2026

    Sesa Care is an Ayurvedic hair care brand. The NCLT is the tribunal that approves company mergers; the merger counts from 1 Apr 2026 and takes effect once statutory filings are done.

    Status: New, recently announced.

  • Rural reach

    Early

    Target: over 100,000 villages served directly

    Bhalla set the target on 5 Nov 2026. The FY26 annual report gives total village coverage of 1.33 lakh villages and does not say how many of these are served directly.

    Status: Early, too early to judge.

Status compares progress with what the company itself said it would do: Working = on track against what the company said; Mixed = partly on track; Behind = behind the company's own plan; New = recently announced; Early = too early to judge.

17Financial strength and debt

17Financial strength · 31 Mar 2026

How much debt does Dabur have?

On 31 Mar 2026 Dabur's cash and investments were ₹8,426 crore more than its borrowings; FY26 operating cash flow was ₹2,579 crore.
  • Total debt₹1,063 cr
  • Cash and investments₹9,489 cr
  • Net cash (cash minus debt)₹8,426 cr
  • Net worth (shareholders' money)₹11,803 cr
Debt to equity
0.09×
₹ of debt for every ₹1 of shareholders' money
Interest cover
21×
how many times operating profit covers interest
Contingent liabilities
₹820 cr
possible future payments, e.g. disputed claims
  • Borrowings were ₹868 crore on 31 Mar 2022, ₹1,158 crore on 31 Mar 2024, ₹730 crore on 31 Mar 2025 and ₹1,063 crore on 31 Mar 2026. On 30 Sep 2026 they were ₹1,242 crore.
  • Cash and investments include long-term investments of ₹4,331 crore; the company counts them in its own figure of ₹9,489 crore.
  • Lease liabilities (₹225 crore on 31 Mar 2026) are not counted as borrowings here.
  • Contingent liabilities (claims not provided for) were ₹820 crore on 31 Mar 2026, up from ₹659 crore; sales tax claims rose to ₹684 crore from ₹62 crore.
  • Debt to equity = borrowings ÷ total equity of ₹11,803 crore (Cityfort calculation from the FY26 annual report). The annual report's own ratio table gives 0.14 for FY26 (0.09 for FY25), on the company's own basis. Interest cover of 21.0 times is the company's figure.
18Who owns it

18Who owns it · Q2 FY27

Who owns Dabur?

  • Promoters (founders or parent company)66.3%
  • Foreign institutions (FII)9.6%
  • Indian institutions (DII)18.4%
  • Public and others5.8%

Promoter pledge

No promoter shares were pledged in Q2 FY27.

How ownership changed
Dabur shareholding by quarter, %
QuarterPromotersFIIDIIPublicPledged*
Q3 FY2466.2%16.5%11.8%5.5%0.0%
Q4 FY2466.3%15.8%12.6%5.4%0.0%
Q1 FY2566.2%15.0%13.6%5.2%0.0%
Q2 FY2566.3%15.0%13.7%5.0%0.0%
Q3 FY2566.3%13.3%14.9%5.6%0.0%
Q4 FY2566.3%12.7%15.7%5.4%0.0%
Q1 FY2666.2%11.9%16.2%5.7%0.0%
Q2 FY2666.2%10.9%17.4%5.5%0.0%
Q3 FY2666.2%10.1%18.4%5.3%0.0%
Q4 FY2666.3%10.0%18.6%5.2%0.0%
Q1 FY2766.2%9.7%18.7%5.4%0.0%
Q2 FY2766.3%9.6%18.4%5.8%0.0%

* Pledged = share of the promoters' own holding reported as pledged. In older filings this can include shares “otherwise encumbered”; the governance flags say when.

19What it does with profit

19What it does with profit

What does Dabur do with its profit?

Dividend per share = interim + final for each year (FY26 final of ₹5.50 as recommended by the board). Payout = dividend per share ÷ basic earnings per share (Cityfort calculation). Cash paid: ₹966 crore in FY24, ₹975 crore in FY25 and ₹1,419 crore in FY26. The board declared a ₹3.50 interim dividend for FY27 on 4 Nov 2026 (record date 10 Nov 2026).

Dividend per share

₹8.25FY26

Dividend paid for each share, by financial year.

₹ per share

See the numbers
Dividend per share (₹ per share)
YearDividend per shareShare of profit paid out
FY22₹5.2052.8%
FY23₹5.2053.9%
FY24₹5.5052.9%
FY25₹8.0080.2%
FY26₹8.2577.2%

No buybacks or fund raises in the period covered.

20Governance signals

20Governance signals

What do Dabur's governance filings show?

Auditor
G. Basu & Co., since 2022
Auditor changes
12 Aug 2022: Walker Chandiok & Co LLP → G. Basu & Co. (Shareholders appointed G. Basu & Co. at the 12 Aug 2022 AGM for five years, to the AGM in 2027. Walker Chandiok signed the FY22 accounts.)
Audit qualifications
None reported
Related-party dealings
The promoter group, the Burman family, held 66.25% on 30 Sep 2026 with no shares pledged. Four of the 12 directors are non-executive promoter directors, including chairman Mohit Burman; six are independent.
Credit rating
CRISIL CRISIL AAA (long term), CRISIL A1+ (short term) (outlook Stable), 17 Nov 2026

A credit rating describes the company's ability to repay debt. It is not a rating of the share.

Flags to know about

  • regulatory · 6 Nov 2026

    SEBI administrative warning, Nov 2026

    On 6 Nov 2026 SEBI sent an administrative warning letter alleging a delay in disclosing a US FDA warning letter received on 24 Jul 2026. The company said there is no financial or operational impact and that it will address the concern.

  • regulatory · 10 Jun 2026

    US FDA import alert on one plant

    On 10 Jun 2026 the US FDA put drugs made at the Silvassa plant on Import Alert 66-40 after an inspection found data-integrity and maintenance lapses. The company says this covers a small part of the plant making private-label products, with insignificant revenue.

  • regulatory · 7 Aug 2026

    FSSAI order on "100%" claims, stayed by court

    On 3 Aug 2026 food regulator FSSAI barred the use of "100%" on a few food products and their sale. The Delhi High Court stayed the order on 7 Aug 2026; the next hearing is on 16 Dec 2026.

  • regulatory · 4 Aug 2026

    Small penalties in 2026

    An Almora magistrate imposed a ₹4 lakh penalty for alleged labelling breaches under the food safety law; the company said it will appeal. Dabur paid a ₹25.39 lakh GST penalty on 4 Aug 2026 to close an audit about input tax credit.

  • other · 13 Nov 2026

    Global CEO resigned in Nov 2026

    Mohit Malhotra resigned as Global CEO and whole-time director with effect from 13 Nov 2026. Herjit Singh Bhalla, CEO of the India business, joined the board; P. D. Narang oversees the international business.

21How it got here

21How it got here

How did Dabur get here?

  1. 1884

    Milestone

    Founded in Calcutta

    Dabur began in 1884 in a small pharmacy in Calcutta (now Kolkata), the company says.

  2. 2023

    Business-model change

    Bought into Badshah spices

    The FY26 annual report lists Badshah Masala as a 51% subsidiary from 2 Jan 2023, taking Dabur into spice blends.

  3. 2024

    Milestone

    Sesa Care deal announced

    In Oct 2024 Dabur agreed to merge Sesa Care, an Ayurvedic hair care brand, first buying 51% of its preference shares from True North.

  4. 2026

    Crisis

    US FDA import alert

    On 10 Jun 2026 the US FDA put drugs made at the Silvassa plant on an import alert; the company says the revenue involved is insignificant.

  5. 2026

    Crisis

    FSSAI order stayed

    FSSAI barred "100%" claims on a few food products on 3 Aug 2026; the Delhi High Court stayed the order on 7 Aug 2026.

  6. 2026

    Milestone

    Sesa Care merger sanctioned

    The NCLT New Delhi bench sanctioned the merger on 24 Sep 2026, counting from 1 Apr 2026.

  7. 2026

    Business-model change

    No more global CEO

    Global CEO Mohit Malhotra resigned with effect from 13 Nov 2026; India and international businesses now report to separate leaders.

22Sources and changes

Where every number on this page comes from

Sources (28 documents)
  1. S1Integrated Annual Report FY26 (2025-26) · Dabur India Ltd · Tier 1: company or exchange filing · 6 Jul 2026
  2. S2Integrated Annual Report FY25 (2024-25) · Dabur India Ltd · Tier 1: company or exchange filing · 9 Jul 2025
  3. S3Integrated Annual Report FY24 (2023-24) · Dabur India Ltd · Tier 1: company or exchange filing · 10 Jul 2024
  4. S4Integrated Annual Report FY23 (2022-23) · Dabur India Ltd · Tier 1: company or exchange filing
  5. S5Annual Report FY22 (2021-22) · Dabur India Ltd · Tier 1: company or exchange filing
  6. S7Q2 FY27 financial results · Dabur India Ltd · Tier 1: company or exchange filing · 4 Nov 2026
  7. S9Q2 FY27 press release · Dabur India Ltd · Tier 1: company or exchange filing · 4 Nov 2026
  8. S10Q2 FY27 analyst/investor meet transcript (5 Nov 2026) · Dabur India Ltd · Tier 1: company or exchange filing · 5 Nov 2026
  9. S11Q1 FY27 financial results · Dabur India Ltd · Tier 1: company or exchange filing · 29 Jul 2026
  10. S14Q1 FY27 earnings call transcript · Dabur India Ltd · Tier 1: company or exchange filing · 3 Aug 2026
  11. S15Q4 FY26 financial results · Dabur India Ltd · Tier 1: company or exchange filing · 7 May 2026
  12. S16Q4 FY26 investor communication · Dabur India Ltd · Tier 1: company or exchange filing · 7 May 2026
  13. S17Q4 FY26 earnings call transcript · Dabur India Ltd · Tier 1: company or exchange filing · 12 May 2026
  14. S19Q3 FY26 earnings call transcript · Dabur India Ltd · Tier 1: company or exchange filing · 3 Feb 2026
  15. S20Q2 FY26 earnings call transcript · Dabur India Ltd · Tier 1: company or exchange filing · 6 Nov 2025
  16. S23Credit rating filing (Reg 30) · Dabur India Ltd (NSE/BSE filing) · Tier 1: company or exchange filing · 17 Nov 2026
  17. S24Resignation of Global CEO, board and KMP changes · Dabur India Ltd (NSE/BSE filing) · Tier 1: company or exchange filing · 4 Nov 2026
  18. S25SEBI administrative warning letter (Reg 30) · Dabur India Ltd (NSE/BSE filing) · Tier 1: company or exchange filing · 6 Nov 2026
  19. S26Update on performance and demand trends · Dabur India Ltd (NSE/BSE filing) · Tier 1: company or exchange filing · 6 Oct 2026
  20. S28NCLT order pronouncement, scheme of arrangement · Dabur India Ltd (NSE/BSE filing) · Tier 1: company or exchange filing · 25 Sep 2026
  21. S30Update on letters dated 4 and 7 Aug 2026 (Reg 30) · Dabur India Ltd (NSE/BSE filing) · Tier 1: company or exchange filing · 25 Aug 2026
  22. S32Delhi High Court stay order · Dabur India Ltd (NSE/BSE filing) · Tier 1: company or exchange filing · 7 Aug 2026
  23. S33GST audit observations (Reg 30) · Dabur India Ltd (NSE/BSE filing) · Tier 1: company or exchange filing · 4 Aug 2026
  24. S35Quarterly update Q1 FY27 · Dabur India Ltd (NSE/BSE filing) · Tier 1: company or exchange filing · 3 Jul 2026
  25. S36US FDA import alert (Reg 30) · Dabur India Ltd (NSE/BSE filing) · Tier 1: company or exchange filing · 11 Jun 2026
  26. S37Rumour verification: US drug regulator news item · Dabur India Ltd (NSE/BSE filing) · Tier 1: company or exchange filing · 1 Jun 2026
  27. S39Penalty imposed (Reg 30) · Dabur India Ltd (NSE/BSE filing) · Tier 1: company or exchange filing · 10 Apr 2026
  28. S41NSE results and shareholding XBRL facts (12 quarters, 5 years) · NSE / Dabur India Ltd · Tier 1: company or exchange filing · 19 Nov 2026
Changes to this page (v1 · 19 Nov 2026)
  1. v1 · 19 Nov 2026First version. (first version)

Numbers come only from tier 1 and tier 2 sources. Read how we research.

Disclaimer

For learning only. Cityfort is not a SEBI-registered adviser and does not recommend buying or selling any security. Prices shown are dated and may be out of date.

Investing in securities involves risk, including loss of capital. Before making any investment decision, do your own research and consider consulting a SEBI-registered investment adviser.

Cityfort, its owners and contributors may or may not hold securities of companies covered. Content is not an offer or solicitation to buy or sell any security.

Read the full disclaimer

Cityfort publishes educational content that explains how listed companies work. Cityfort is not registered with the Securities and Exchange Board of India (SEBI) as an Investment Adviser or Research Analyst and does not provide investment advice, recommendations, ratings, price targets or any opinion on whether to buy, sell or hold any security.

All information is taken from publicly available sources, mainly company filings on BSE and NSE, which are listed on each page with dates. We work to keep it accurate and correct errors publicly, but we do not guarantee that it is complete, accurate or up to date. Any market price or price-based ratio shown is dated, may be out of date by the time you read it, and is included only to explain concepts.

Statements by company management are reported as statements, with their date and source; they are not our forecasts.